3-(4-Morpholinyl)-1-propanol structure
|
Common Name | 3-(4-Morpholinyl)-1-propanol | ||
|---|---|---|---|---|
| CAS Number | 4441-30-9 | Molecular Weight | 145.199 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 251.6±25.0 °C at 760 mmHg | |
| Molecular Formula | C7H15NO2 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 105.9±23.2 °C | |
| Symbol |
GHS05 |
Signal Word | Danger | |
| Name | 4-(3-Hydroxypropyl)morpholine |
|---|---|
| Synonym | More Synonyms |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 251.6±25.0 °C at 760 mmHg |
| Molecular Formula | C7H15NO2 |
| Molecular Weight | 145.199 |
| Flash Point | 105.9±23.2 °C |
| Exact Mass | 145.110275 |
| PSA | 32.70000 |
| LogP | -1.20 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.470 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H314 |
| Precautionary Statements | P260-P280-P303 + P361 + P353-P304 + P340 + P310-P305 + P351 + P338 |
| Hazard Codes | Xi:Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | UN 3267 8 / PGI |
| WGK Germany | 2 |
| RTECS | QE9104700 |
| HS Code | 2934999090 |
| Precursor 10 | |
|---|---|
| DownStream 8 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
The novel HDAC inhibitor AR-42-induced anti-colon cancer cell activity is associated with ceramide production.
Biochem. Biophys. Res. Commun. 463 , 545-50, (2015) In the current study, we investigated the potential activity of AR-42, a novel histone deacetylase (HDAC) inhibitor, against colon cancer cells. Our in vitro results showed that AR-42 induced ceramide... |
|
|
Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis.
BMC Cancer 9 , 67, (2009) The prerequisite for the potential use of the bacterial toxin verotoxin-1 in the treatment of breast cancer was investigated by first determining the expression of its receptor Gb3 (CD77) in clinical ... |
| 3-(4-Morpholinyl)-1-propanol |
| 4-Morpholinepropanol |
| 3-Morpholino-1-propanol |
| 3-(4-Morpholinyl)-1-propanol,3-Morpholinopropanol |
| 4-(3-Hydroxypropyl)Morpholine |
| 3-Morpholinopropanol |
| 3-morpholin-4-ylpropan-1-ol |
| 3-(morpholin-4-yl)propan-1-ol |
| MFCD01713533 |
| 3-Morpholin-4-yl-propan-1-ol |